Bio-tech used to be an upside leader over the broad market coming off the 2009 lows. Bio-tech gave up its leadership back in 2015, where it peaked and started under performing the broad market. Over the past 15-months, Biotech has started acting a little better.

Below looks at Bio-tech ETF XBI and updates the pattern is has been forming of late.


Bio-tech ETF XBI is in an uptrend since the lows in early 2016. Of late it looks to have formed a bullish ascending triangle and is working on a breakout at (1).

We highlighted two overhead tests that could become potential resistance zones that could become overhead tests.


How The Recent Decline In Stocks Looks "Eerily" Like Major Bear Markets Of The Past